Browse by Section 100 Item List

Efficient Funding of Chemotherapy – Related Benefits

Further information can be found in the Explanatory Notes.

  • Legend
  • MPMedical Practitioner
  • SO
    Products that are in a Supply Only state will be available for dispensing, but not for prescribing. PBS Prescriptions written prior to the Supply Only period are able to be dispensed using either the Supply Only product where available, or an equivalent product as specified on the PBS schedule.
    Supply Only
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MP 2550F APREPITANTaprepitant 165 mg capsule, 1 1 1 5
MP 5886T FOLINIC ACIDfolinic acid 100 mg/10 mL injection, 10 mL vial 1 10 1
MP 1904F FOLINIC ACIDfolinic acid 100 mg/10 mL injection, 10 x 10 mL ampoules 1 10 1
MP 5890B FOLINIC ACIDfolinic acid 50 mg/5 mL injection, 5 mL vial 10 10 2
MP 1899Y FOLINIC ACIDfolinic acid 50 mg/5 mL injection, 10 x 5 mL ampoules 1 10 2
MP 5870Y FOLINIC ACIDfolinic acid 300 mg/30 mL injection, 30 mL vial 4 4 1
MP 5904R FOLINIC ACIDfolinic acid 15 mg tablet, 10 1 10 0
MP 11103J FOSAPREPITANTfosaprepitant 150 mg injection, 1 vial 1 1 5
MP 5899L GRANISETRONgranisetron 3 mg/3 mL injection, 3 mL ampoule 1 1 0
MP 5898K GRANISETRONgranisetron 2 mg tablet, 1 2 2 0
MP 5949D INTERFERON ALFA-2Ainterferon alfa-2a 9 million units (33.333 microgram)/0.5 mL injection, 0.5 mL syringe 5 5 5
MP 5998Q INTERFERON ALFA-2Ainterferon alfa-2a 9 million units (33.333 microgram)/0.5 mL injection, 0.5 mL syringe 5 5 4
MP 5945X INTERFERON ALFA-2Ainterferon alfa-2a 3 million units (11.111 microgram)/0.5 mL injection, 0.5 mL syringe 15 15 4
MP 5946Y INTERFERON ALFA-2Ainterferon alfa-2a 3 million units (11.111 microgram)/0.5 mL injection, 0.5 mL syringe 15 15 5
MP 5960Q MESNAmesna 400 mg/4 mL injection, 15 x 4 mL ampoules 1 15 5
MP 5961R MESNAmesna 1 g/10 mL injection, 15 x 10 mL ampoules 1 15 5
MP 5902P MYCOBACTERIUM BOVIS (BACILLUS CALMETTE AND GUERIN (BCG)) TICE STRAINMycobacterium bovis (Bacillus Calmette and Guerin (BCG)) Tice strain 500 million CFU injection, 3 vials 1 3 1
MP 10714X NETUPITANT + PALONOSETRONnetupitant 300 mg + palonosetron 500 microgram capsule, 1 1 1 5
MP 5968D ONDANSETRONondansetron 8 mg tablet, 4 1 4 0
MP 5967C ONDANSETRONondansetron 4 mg tablet, 4 1 4 0
MP 5857G ONDANSETRONondansetron 4 mg orally disintegrating tablet, 4 1 4 0
MP 5969E ONDANSETRONondansetron 4 mg wafer, 4 1 4 0
MP 5858H ONDANSETRONondansetron 8 mg orally disintegrating tablet, 4 1 4 0
MP 5970F ONDANSETRONondansetron 8 mg wafer, 4 1 4 0
MP 5848T ONDANSETRONondansetron 4 mg/5 mL oral liquid, 50 mL 1 1 0
MP 5853C PALONOSETRONpalonosetron 250 microgram/5 mL injection, 5 mL vial 1 1 0
MP 10708N RITUXIMABrituximab 1.4 g/11.7 mL injection, 11.7 mL vial 1 1 5
MP 10710Q RITUXIMABrituximab 1.4 g/11.7 mL injection, 11.7 mL vial 1 1 11
MP 10720F RITUXIMABrituximab 1.4 g/11.7 mL injection, 11.7 mL vial 1 1 7
MP 10741H RITUXIMABrituximab 1.4 g/11.7 mL injection, 11.7 mL vial 1 1 6
MP 11942M RITUXIMABrituximab 1.4 g/11.7 mL injection, 11.7 mL vial 1 1 2
MP 10743K TRASTUZUMABtrastuzumab 600 mg/5 mL injection, 5 mL vial 1 1 3
MP 10811B TRASTUZUMABtrastuzumab 600 mg/5 mL injection, 5 mL vial 1 1 0
MP 10817H TRASTUZUMABtrastuzumab 600 mg/5 mL injection, 5 mL vial 1 1 3
MP 5987D TROPISETRONtropisetron 5 mg/5 mL injection, 5 mL ampoule 1 1 0